BRAIN Initiative Asks for $4.5B

An advisory committee for the BRAIN Initiative says that to fully fund the goals of the neuroscience research program, taxpayers should fork over $4.5 billion.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, MIROSLAW MAGOLAA widely applauded program to advance techniques for understanding the brain, called the BRAIN Initiative, already has an investment of $40 million from the National Institutes of Health (NIH) and a request in to Congress from President Obama for $100 million. But a report from a BRAIN Initiative advisory committee, released last week (June 5), says the real price tag to accomplish the program’s goals is $4.5 billion.

NIH Director Francis Collins said in a press release that the dollar amounts in the report “represent a realistic estimate of what will be required for this moon shot initiative.”

The focus of the BRAIN Initiative is to develop neuroscience approaches over the next decade that will allow for a deeper and more expansive interrogation of the brain’s neurocircuitry and how it functions in health and disease. In addition, the program—if fully funded—will also invest in creating a census of brain cells and a road map of their circuitry and advancing tools for neural monitoring and manipulating brain circuits, among others.

“Our cost estimates are extremely optimistic,” the committee members wrote. “Developing a single new stimulating or recording device for humans up through FDA [Food ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies